ConductScience.org, home

Paper41326795

RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer.

Treekitkarnmongkol W and 19 others. Nat Cell Biol, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer. Papers, record 41326795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41326795

Download JSON
Cell line
PANC-1348 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer.
PubMed
Journal
Nat Cell Biol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-13
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Treekitkarnmongkol WWarapenhttps://orcid.org/0000-0002-7542-5201
2Katayama HHiroshihttps://orcid.org/0000-0003-1821-0260
3Sankaran DDeivendranhttps://orcid.org/0000-0001-5837-2083
4Tai MCMei-Chee
5Rauth SSanchita
6Chen HHanxiao
7Nguyen TTristianhttps://orcid.org/0009-0000-4565-1534
8Hara KKieko
9Thege FIFredrik Ihttps://orcid.org/0000-0002-1822-4526
10Ponnusamy MPMoorthy P
11Batra SKSurinder Khttps://orcid.org/0000-0001-9470-9317
12Wang HHuaminhttps://orcid.org/0000-0002-2038-5863
13Wistuba IIIgnacio I
14Schmittgen TDThomas Dhttps://orcid.org/0000-0002-2812-8546
15Heymach JVJohn Vhttps://orcid.org/0000-0001-9068-8942
16Kopetz SScotthttps://orcid.org/0000-0001-9647-3416
17Hu TTony
18Yao WWantong
19Maitra AAnirbanhttps://orcid.org/0000-0001-7923-9978
20Sen SSubratahttps://orcid.org/0000-0001-6884-6246

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proto-Oncogene Proteins p21(ras)Major topic
MutationMajor topic
Pancreatic NeoplasmsMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Colorectal NeoplasmsMajor topic
Humans
Animals
Signal Transduction
MicroRNAs
Cell Line, Tumor
Feedback, Physiological
Mice
Gene Expression Regulation, Neoplastic
Xenograft Model Antitumor Assays
ErbB Receptors
Mice, Nude
Cell Proliferation

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMedNIH RePORTER
U01 CA214263NCI NIH HHSUnited StatesU01CA214263PubMedNIH RePORTER
U01 CA252965NCI NIH HHSUnited StatesU01CA252965PubMedNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121245048NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells.Nucleic Acids Res2011https://conductscience.org/library/papers/21245048PubMed
239529638Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples.Gastro Hep Adv2024https://conductscience.org/library/papers/39529638PubMed
334096690Sotorasib for Lung Cancers with KRAS p.G12C Mutation.N Engl J Med2021https://conductscience.org/library/papers/34096690PubMed
425323927Drugging the undruggable RAS: Mission possible?Nat Rev Drug Discov2014https://conductscience.org/library/papers/25323927PubMed
531062644Anchorage-independent growth conditions reveal a differential SOS2 dependence for transformation and survival in RAS-mutant cancer cells.Small GTPases2021https://conductscience.org/library/papers/31062644PubMed
630918400Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.Nature2019https://conductscience.org/library/papers/30918400PubMed
736546651Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.N Engl J Med2023https://conductscience.org/library/papers/36546651PubMed
821113131miR-301a as an NF-κB activator in pancreatic cancer cells.EMBO J2011https://conductscience.org/library/papers/21113131PubMed
924256730K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.Nature2013https://conductscience.org/library/papers/24256730PubMed
1014551139Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein.Blood2004https://conductscience.org/library/papers/14551139PubMed
1137277530An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.Nat Cancer2023https://conductscience.org/library/papers/37277530PubMed
1238637634Targeting KRAS in cancer.Nat Med2024https://conductscience.org/library/papers/38637634PubMed
1331457089Cell cycle progression in confining microenvironments is regulated by a growth-responsive TRPV4-PI3K/Akt-p27Kip1 signaling axis.Sci Adv2019https://conductscience.org/library/papers/31457089PubMed
1430181243Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.Sci Signal2018https://conductscience.org/library/papers/30181243PubMed
1534919824Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.Lancet Oncol2022https://conductscience.org/library/papers/34919824PubMed
1637068173Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.Cancer Discov2023https://conductscience.org/library/papers/37068173PubMed
1721873159Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.Anticancer Res2011https://conductscience.org/library/papers/21873159PubMed
1822340593Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.Cancer Cell2012https://conductscience.org/library/papers/22340593PubMed
1920093556MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.Clin Chem2010https://conductscience.org/library/papers/20093556PubMed
2015766527RAS is regulated by the let-7 microRNA family.Cell2005https://conductscience.org/library/papers/15766527PubMed

See all 39 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42131811Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17.Front Pharmacol2026https://conductscience.org/library/papers/42131811

Source PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41326795

GET https://conductscience.org/api/papers/v1/41326795/references?page=2